INM InMed Pharmaceuticals Inc.

NASDAQ
$1.35

InMed Pharmaceuticals Inc. (INM) is confirmed to report earnings on September 9, 2026, after the market close.

Earnings Date
Sep 9
Wednesday · 6:50 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”) and is developing IntegraSyn™ to produce pharmaceutical-grade cannabinoids.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.